Barclays analysts initiated coverage on Eli Lilly and Company (NYSE:LLY) with a Overweight rating on February 20, 2026. Eli Lilly and Company operates in the Healthcare sector.…
Barclays analysts initiated coverage on Eli Lilly and Company (NYSE:LLY) with a Overweight rating on February 20, 2026.
Eli Lilly and Company operates in the Healthcare sector. The stock currently trades at $1009.52 with a market capitalization of $906.5B. The stock has gained 24.2% over the past 52 weeks.
Current market data
NYSE · LLY
$1,183.46
Up: +$1.83 · +0.15%
Live quote updated
Keep reading
institutional ·
institutional ·
price ·
price ·
